We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+0.52%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$15.3B
AUM Growth
+$933M
(+6.5%)
Cap. Flow
+$1.09B
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
20.85%
Holding
1,816
New
17
Increased
573
Reduced
1,124
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$111M |
| 2 |
Amazon
AMZN
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$91.8M |
| 4 |
Roper Technologies
ROP
|
+$69.8M |
| 5 |
PX
Praxair Inc
PX
|
+$68.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown-Forman Class B
BF.B
|
+$28.4M |
| 2 |
Becton Dickinson
BDX
|
+$28M |
| 3 |
W.W. Grainger
GWW
|
+$20.5M |
| 4 |
Lowe's Companies
LOW
|
+$15M |
| 5 |
Target
TGT
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Financials | 13.66% |
| 3 | Healthcare | 12.92% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MFA
926
MFA Financial
MFA
$929M
| $778K | 0.01% |
25,818
-432
| -2% | -$12.8K |
|
|
IMGN
927
DELISTED
Immunogen Inc
IMGN
| $778K | 0.01% |
73,914
-12,162
| -14% | -$120K |
|
928
Pacira BioSciences
PCRX
$1.02B
| $777K | 0.01% |
24,948
-3,837
| -13% | -$137K |
|
|
TECD
929
DELISTED
Tech Data Corp
TECD
| $777K | 0.01% |
9,130
-701
| -7% | -$68.2K |
|
930
Invesco Mortgage Capital
IVR
$776M
| $766K | 0.01% |
4,678
-289
| -6% | -$47.6K |
|
931
CACI
CACI
$10.8B
| $765K | 0.01% |
5,056
-380
| -7% | -$55.5K |
|
932
Lamb Weston
LW
$6.82B
| $760K | 0.01% |
13,047
-579
| -4% | -$32.8K |
|
933
International Bancshares
IBOC
$4.77B
| $759K | ﹤0.01% |
19,499
-1,204
| -6% | -$48.8K |
|
|
GLIBA
934
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $759K | ﹤0.01% |
+14,361
| New | +$753K |
|
935
Trustmark
TRMK
$2.73B
| $756K | ﹤0.01% |
24,266
-1,471
| -6% | -$47.4K |
|
936
Globus Medical
GMED
$10.4B
| $754K | ﹤0.01% |
15,133
-1,598
| -10% | -$75.1K |
|
|
PGRE
937
DELISTED
Paramount Group
PGRE
| $753K | ﹤0.01% |
52,869
-1,006
| -2% | -$14.7K |
|
|
WR
938
DELISTED
Westar Energy Inc
WR
| $753K | ﹤0.01% |
14,317
-1,301
| -8% | -$65.7K |
|
|
ENDP
939
DELISTED
Endo International plc
ENDP
| $747K | ﹤0.01% |
125,693
-17,869
| -12% | -$125K |
|
940
Brink's
BCO
$5.02B
| $746K | ﹤0.01% |
10,461
-1,117
| -10% | -$85.8K |
|
941
Ingevity
NGVT
$2.55B
| $745K | ﹤0.01% |
10,106
-699
| -6% | -$52.3K |
|
|
ICPT
942
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $744K | ﹤0.01% |
12,092
-1,912
| -14% | -$115K |
|
943
Avis
CAR
$5.63B
| $741K | ﹤0.01% |
15,820
-1,787
| -10% | -$80.5K |
|
944
Theravance Biopharma
TBPH
$874M
| $741K | ﹤0.01% |
30,556
-4,791
| -14% | -$132K |
|
945
Southwest Gas
SWX
$6.74B
| $739K | ﹤0.01% |
10,924
-1,333
| -11% | -$94.7K |
|
|
ALEX
946
DELISTED
Alexander & Baldwin
ALEX
| $738K | ﹤0.01% |
31,893
+8,796
| +38% | +$220K |
|
947
Federated Hermes
FHI
$4.4B
| $733K | ﹤0.01% |
21,944
-159
| -0.7% | -$5.4K |
|
|
EXAS
948
DELISTED
Exact Sciences
EXAS
| $730K | ﹤0.01% |
18,110
-2,583
| -12% | -$126K |
|
|
PDCE
949
DELISTED
PDC Energy, Inc.
PDCE
| $730K | ﹤0.01% |
14,894
-1,722
| -10% | -$90.7K |
|
950
Valvoline
VVV
$4.97B
| $727K | ﹤0.01% |
32,847
-88
| -0.3% | -$2.09K |
|
Similar funds
ProShare Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, ProShare Advisors held 1,816 positions worth $15.3B, up 6.5% from $14.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $1.09B of net new capital in Q1 2018, opening 17 new positions and adding to 573 existing holdings. Its largest new stake was CoStar Group: 93,260 shares worth $3.38M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Brown-Forman Class B, an estimated $28.4M trimmed.
- ProShare Advisors's largest Q1 2018 buy was CoStar Group: 93,260 shares worth $3.38M.
- ProShare Advisors added most to Apple in Q1 2018, an estimated $111M increase.
- ProShare Advisors's biggest Q1 2018 reduction was Brown-Forman Class B, cutting an estimated $28.4M.
- ProShare Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $3.8M.
- ProShare Advisors's ten largest holdings make up 21% of its $15.3B portfolio in Q1 2018.
- ProShare Advisors opened 17 new positions and closed 101 in Q1 2018.
- ProShare Advisors's portfolio value rose 6.5% quarter-over-quarter to $15.3B.
Based on ProShare Advisors's 13F filing for Q1 2018, filed 14 May 2018.